Suchergebnisse - "Fassl, Anne"

PubPharm (44)

1

Feasibility of Next-generation Sequencing of Liquid Biopsy (Circulating Tumor DNA) Samples and Tumor Tissue from Patients with Metastatic Prostate Cancer in a Real-world Clinical Setting in Germany

enthalten in: European urology focus | 2024

von Mandel, P. | Hoeh, B. | Humke, C. | +18

2

PC4 : A new regulator of cyclin D1 transcript levels

enthalten in: The Journal of cell biology | 2024

von Fassl, A. | Sicinski, P.

CommentOn: J Cell Biol. 2024 Mar 4;223(3):. - PMID 38349334

3

Heterogeneity and transcriptional drivers of triple-negative breast cancer

enthalten in: Cell reports | 2023

von Jovanović, B. | Temko, D. | Stevens, L. | +35

4

JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States

enthalten in: Cancer research | 2023

von Stevens, L. | Peluffo, G. | Qiu, X. | +30

5

Interrogating Kinase-Substrate Relationships with Proximity Labeling and Phosphorylation Enrichment

enthalten in: Journal of proteome research | 2022

von Zhang, T. | Fassl, A. | Vaites, L. | +4

6

CDK4 and CDK6 kinases : From basic science to cancer therapy

enthalten in: Science (New York, N.Y.) | 2022

von Fassl, A. | Geng, Y. | Sicinski, P.

7

Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer

enthalten in: Nature communications | 2021

von Dang, F. | Nie, L. | Zhou, J. | +13

8

Targeting Aberrant FGFR Signaling to Overcome CDK4/6 Inhibitor Resistance in Breast Cancer

enthalten in: Cells | 2021

von Sobhani, N. | Fassl, A. | Mondani, G. | +2

9

The requirement for cyclin E in c-Myc overexpressing breast cancers

enthalten in: Cell cycle (Georgetown, Tex.) | 2020

von Zhou, Y. | Geng, Y. | Zhang, Y. | +6

10

Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition

enthalten in: Science advances | 2020

von Fassl, A. | Brain, C. | Abu-Remaileh, M. | +26

1
2
3
4
5
Nächster »
[5]